Dr. Herrick would be favorably impressed with the current aggressive early approach to treatment of patients with acute myocardial infarction, particularly with the use of coronary thrombolysis. In a presentation to the Association of American Physicians in 1912, Dr. Herrick stated: "But there are reasons for believing that even larger branches of the coronary arteries may be occluded -at times acutely occluded without resulting death, at least without death in the immediate future."2 Dr. Herrick's initial observations elicited little interest when presented in 1912, but were later acknowledged when his second presentation to the same group in 1918 included data from animal studies by one of his colleagues, Dr. Fred Smith, which further supported the role of coronary thrombosis in acute myocardial infarction.3 Thus, Herrick's clinical insight into the pathogenesis of acute coronary syndromes preceded the common use of coronary thrombolysis by about 70 years.
There are many factors other than our ability to reopen many occluded coronary arteries that have influenced current trends in clinical cardiology. With the rapid clinical application of important research advances, the widespread use of multiple diagnostic tests, and the effective treatment of an increasing number of patients with cardiovascular disease, cardiology care has never been better. However, the future practice of cardiology, as we know it, is in some jeopardy. In balancing the important advantages of modem diagnostic and therapeutic approaches against the expense of sometimes unnecessary high-technology procedures for a large number of patients, we cardiologists must be careful to avoid short-term gain at the cost of longterm disaster, resulting in what Barbara Tuchman termed in her recent best seller "a march of folly."4
Problems facing cardiology. As most members of the health care delivery team clearly recognize, there are many major problems facing medicine and its subspecialty of cardiology in 1986. Most of these relate to the skyrocketing costs of medical care in the United States, since they now comprise almost 12% of the gross national product.5 Related problems include: a surplus of physicians (including cardiologists), an increasing elderly population, the relative costliness of high-technology procedures, and the increasing expense of malpractice insurance.
Since the early 1960s when a deliberate effort was made to increase the number of U.S. physicians, there has been an alarming increase in the number of physicians per 100,000 people, from 141 to about 220.`8
Although the physician/population ratio is only one of several methods for assessing the The increasing number of patients over age 65 presents a major problem for future health care delivery to patients with cardiovascular disease. Currently, the elderly form approximately 12% of the patient population, but utilize about 30% of health care funds and resources.5 1 Although the mortality rate among the elderly has declined, the Medicare trust fund is out of balance and multiple attempts to reduce the cost of health delivery to patients over 65 have been relatively unsuccessful. Cardiovascular disease is more common in this expanding group of geriatric patients, and diagnostic tests and therapeutic procedures are being applied with great success to this age group. There have been several proposed solutions to this "need-cost" problem, all of which imply a need for some reduction in medical benefits.12' 13 However, no physician wants to restrict medical care to any group of patients for whom it is appropriate. It should be emphasized that working with limited resources is a problem to be dealt with by our society and not only by the medical profession or by legislators. 4 Also, instituting and maintaining standards of quality care is the unique capability and responsibility of the medical profession.`' A question of major importance to the health care profession, to legislators, and to the general public is whether or not the benefits of current trends in clinical cardiology, including the frequent use of high technology, outweigh the cost. A reduction in the age-adjusted mortality from cardiovascular disease of about 30% in the past 10 years probably has resulted from many The expense of malpractice insurance and the payments to patients resulting from often unnecessary litigation increase the physician's fees for patient services. Also, the necessity of practicing "defensive cardiology" results in more noninvasive and invasive testing, even when the yield is likely to be low. In some specialties, such as obstetrics, the high cost of malpractice insurance has influenced physicians to 1098 CIRCULATION change their role in health care delivery. Cardiologists, particularly those involved in "low volume" procedures, are being similarly affected.
The practice of cardiology. The impact of the previously mentioned factors on the practice of cardiology is great now and will be even greater in the near future. Outpatient cardiac catheterization laboratories are increasing in number and caseload on a daily basis due to the lower patient costs involved in the performance of catheterization without hospitalization. Noninvasive testing is being performed with increasing frequency in private practice centers rather than hospital laboratories. Periods of hospitalization tend to be shorter and many cardiologists will accept all Medicare assignments in order to maintain an active practice. There is an increasing percentage of cardiologists agreeing to see general medical patients and, in cities where competition is most intense, cardiologists have joined Health Maintenance Organizations as full-time subspecialists, cardiology consultants, or even primary care physicians. Due to the competition inherent in private practice, some cardiologists now participate in corporate medical health delivery programs and others have opted for a career in academic medicine. All of these events have a major effect on health care delivery for patients with cardiovascular disease.
Some additional factors will also influence the practice of cardiology in the next few years. With the amount of funding to physicians according to diagnostic related groups or their equivalent, the number of patient consultations will likely be markedly reduced. There will be less use of hospital's diagnostic services in order to keep the patient's overall medical bill within the assigned limit. Also, invasive procedures will be performed less commonly by cardiologists in "'open" laboratories, particularly by those who perform infrequent studies. In addition, there will be a diminished level of fellowship support due to a reduction in both federal and hospital funds for subspecialty training. Finally, the overall income for most cardiologists, when corrected for inflation, will decrease in the near future as compared with that in recent years.
Specific There are potential solutions to the dilemmas facing academic cardiology. Adequate and extensive research training must be provided for the majority of future academic cardiologists, even if it requires decreasing the total number of trainees. Also important are upfront incentives for academic cardiologists who generate patient care and research monies. Prospective promotion criteria should be formalized recognizing the important role of the clinician-teacher in academic cardiology in a department of medicine. Improved funding of meritorious clinical investigation is also a necessity for the future of academic cardiology. As acknowledged by most authorities responsible for the federal or volunteer health agency funding of research grant applications,19 the competent clinical investigator is truly an endangered species in 1986. This term was first used to describe the plight of the clinical investigator by Dr. James Warren in 1976 during his acceptance of that year's James B. Herrick Award. 20 The future of cardiology. Considering the multiple positive and negative factors affecting cardiologists in 1986, are the current trends in clinical cardiology a march of folly? As an optimist, I believe they are not.
There has been an important decline in mortality from cardiovascular disease that has been partially due to the improved diagnostic and therapeutic modalities used by many well-trained cardiologists, the "doers" of internal medicine. In the future, further decreases in morbidity and mortality should occur as additional advances in basic and clinical research are applied to patients with cardiovascular disease. However, this accomplishment will require a greater number of appropriately trained academic cardiologists and continued and improved funding of clinical research despite the relative reduction in monies available for prolonged in-hospital cardiac care. The number of elderly patients, many of whom have cardiovascular disease, will increase considerably over the next 20 years. Appropriate diagnostic studies and therapeutic procedures should not be rationed to these patients, even though the cost of providing this care will continue to be a major issue for our society. Costly high-technology diagnostic studies and therapeutic procedures should continue to be applied to appropriate patients, but individual cardiologists and other physicians should restrict the use of these studies when cheaper and equally effective alternatives are available. Continuing dialogue between the medical community and representatives of the legal profession will hopefully lead to a reduction in the cost of malpractice insurance, a decrease in unnecessary lawsuits, and a reduction in the cost involved in practicing "defensive cardiology." Such an agreement between the two professions would be advantageous over the long term for both groups and for society in general.
In conclusion, recent progress in clinical cardiology has been praiseworthy, with tangible results that are readily revealed in reduced mortality statistics. While several major problems confront the subspecialty of cardiology, current trends in clinical cardiology (with some thoughtful modifications) will likely not result in a march of folly, but rather in a further reduction in death and disability due to cardiovascular disease and stroke.
